February #32 : An Ad Is an Ad Is an Ad

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Marked Man

Warts and All

Cracker Jack

Names Will Never Hurt You?

War on the Warts

Rub a Drug Flub

Déjà Vu

Green Means Go

The Cutting Edge

Sealed w/KS

Shalala Infections

An Ad Is an Ad Is an Ad

ADAP Tapped

Trojan Wars

Girls on Trial

The Pill Drill

Say What

Tapped for Greatness

My Brother

Honey, Mud, Maggots, and Other Medical Marvels

Carmine’s Story

There Is Hope: Learning to Live With HIV

Crocodile Tears

The Kinsey Sicks



Cocktails: The Morning After

Patrolling the Borders


Instruments of Infection

Hiccup Blues

A New Kind of Waisting

.38 Caliber

The Labors for Your Fruits

Barbed Comments

Party Planner

Hollywood Golightly

At the End of My Hope

Criminal Body

I Got All My Sistahs With Me

Primo Chemo



POZ Stars


Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

February 1998

An Ad Is an Ad Is an Ad

Glaxo plays piggyback with public awareness

When is a “Be Smart” ad not a “Be Smart” ad? When it’s a Combivir ad. Tongues wagged last September after Glaxo Wellcome’s public-service “Be Smart About HIV” graphic, co-launched with two not-for-profits—the National Minority AIDS Council (NMAC) and the National Gay and Lesbian Health Association (NGLHA)—suddenly morphed into a hard sell for its newly approved drug Combivir (AZT and 3TC). The Combivir ad incorporates the same design, colors and theme as the “Be Smart” slick, which provides information on HIV testing and treatment.

“We are not here to help Glaxo sell their drug,” said NMAC’s executive director Paul Kawata. “When I realized the ad was for a product, it felt like total betrayal. Glaxo didn’t consult with us, so it looks like we endorse Combivir—we don’t.”

But, what some call a corporate sleight-of-hand, others see as the next step in a “We Are Family” strategy, according to Glaxo’s Doug Stokke. “The consistency of look between ‘Be Smart’ and Combivir was done with an intent to identify these things as a family of programs,” he said. “We wanted to move forward with the unique design elements put together to support ‘Be Smart.’” He added that NMAC and NGLHA provided no funding for the campaign and maintain no hold on creative elements. “We didn’t intend to confuse people or imply that either organization had any role in supporting the Combivir ad,” Stokke said. “We’ve had discussion with them and they understand.”

“We understand—but we don’t accept the explanation,” Kawata said. “They must make a clear distinction between a public-education campaign and a product-oriented campaign.“

Search: Glaxo, Combivir

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.